Provided By GlobeNewswire
Last update: Aug 31, 2025
Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the Journal of the American College of Cardiology
Read more at globenewswire.comNASDAQ:CYTK (11/3/2025, 11:41:09 AM)
60.88
-2.71 (-4.26%)
Find more stocks in the Stock Screener


